Vericel Corp Ord Stock Performance
| VCEL Stock | USD 42.65 0.92 2.20% |
The entity has a beta of -0.0357, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Vericel Corp are expected to decrease at a much lower rate. During the bear market, Vericel Corp is likely to outperform the market. At this point, Vericel Corp Ord has a negative expected return of -0.41%. Please make sure to validate Vericel Corp's value at risk, accumulation distribution, as well as the relationship between the Accumulation Distribution and day typical price , to decide if Vericel Corp Ord performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Vericel Corp Ord has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in June 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
| Begin Period Cash Flow | 86.9 M |
Vericel Corp Relative Risk vs. Return Landscape
If you would invest 5,751 in Vericel Corp Ord on February 11, 2025 and sell it today you would lose (1,486) from holding Vericel Corp Ord or give up 25.84% of portfolio value over 90 days. Vericel Corp Ord is currently does not generate positive expected returns and assumes 3.3273% risk (volatility on return distribution) over the 90 days horizon. In different words, 29% of stocks are less volatile than Vericel, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Vericel Corp Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vericel Corp's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Vericel Corp Ord, and traders can use it to determine the average amount a Vericel Corp's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.124
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VCEL |
Estimated Market Risk
| 3.33 actual daily | 29 71% of assets are more volatile |
Expected Return
| -0.41 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Vericel Corp is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vericel Corp by adding Vericel Corp to a well-diversified portfolio.
Vericel Corp Fundamentals Growth
Vericel Stock prices reflect investors' perceptions of the future prospects and financial health of Vericel Corp, and Vericel Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vericel Stock performance.
| Return On Equity | 0.0113 | ||||
| Return On Asset | -0.0045 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | (0.24) % | ||||
| Current Valuation | 2.09 B | ||||
| Shares Outstanding | 50.34 M | ||||
| Price To Earning | 357.33 X | ||||
| Price To Book | 7.11 X | ||||
| Price To Sales | 8.81 X | ||||
| Revenue | 237.22 M | ||||
| EBITDA | 16.63 M | ||||
| Cash And Equivalents | 100.69 M | ||||
| Cash Per Share | 2.13 X | ||||
| Total Debt | 98.85 M | ||||
| Debt To Equity | 0.28 % | ||||
| Book Value Per Share | 5.88 X | ||||
| Cash Flow From Operations | 58.16 M | ||||
| Earnings Per Share | 0.05 X | ||||
| Total Asset | 432.72 M | ||||
| Retained Earnings | (392.81 M) | ||||
| Current Asset | 21.1 M | ||||
| Current Liabilities | 15.36 M | ||||
About Vericel Corp Performance
By examining Vericel Corp's fundamental ratios, stakeholders can obtain critical insights into Vericel Corp's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Vericel Corp is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts. Vericel operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 281 people.Things to note about Vericel Corp Ord performance evaluation
Checking the ongoing alerts about Vericel Corp for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Vericel Corp Ord help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Vericel Corp Ord generated a negative expected return over the last 90 days | |
| Vericel Corp Ord has high historical volatility and very poor performance | |
| Over 99.0% of the company outstanding shares are owned by institutional investors |
- Analyzing Vericel Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vericel Corp's stock is overvalued or undervalued compared to its peers.
- Examining Vericel Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vericel Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vericel Corp's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Vericel Corp's stock. These opinions can provide insight into Vericel Corp's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.